Next Article in Journal
What Is the Efficacy of Sotrovimab in Reducing Disease Progression and Death in People with COVID-19 during the Omicron Era? Answers from a Real-Life Study
Next Article in Special Issue
Neutralizing Antibodies against SARS-CoV-2: Importance of Comorbidities in Health Personnel against Reinfections
Previous Article in Journal
An Attempt of a New Strategy in PRV Prevention: Co-Injection with Inactivated Enterococcus faecium and Inactivated Pseudorabies Virus Intravenously
Previous Article in Special Issue
Efficacy, Pharmacokinetics, and Toxicity Profiles of a Broad Anti-SARS-CoV-2 Neutralizing Antibody
 
 
Article

Article Versions Notes

Viruses 2023, 15(8), 1756; https://doi.org/10.3390/v15081756
Action Date Notes Link
article xml file uploaded 17 August 2023 12:58 CEST Original file -
article xml uploaded. 17 August 2023 12:58 CEST Update https://www.mdpi.com/1999-4915/15/8/1756/xml
article pdf uploaded. 17 August 2023 12:58 CEST Version of Record https://www.mdpi.com/1999-4915/15/8/1756/pdf
article html file updated 17 August 2023 12:59 CEST Original file https://www.mdpi.com/1999-4915/15/8/1756/html
Back to TopTop